Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
TNXP
$14.15
+4.12%
TNXP
· Tonix Pharmaceuticals Holding Corp.
$14.15
+0.56 (+4.12%)
At close · Aug 31
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$233.08M
Shares
17.15M
All earnings calls
Earnings call · FY2025 Q4
Tonix Pharmaceuticals Holding Corp. (TNXP) Q4 2025 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$5.39M
+108.8% YoY
Net income · derived Q4
-$46.91M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 13, 2026 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 12, 2026 · complete as-filed document